Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Headache ; 54(8): 1320-36, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24862836

ABSTRACT

OBJECTIVE: To describe the demographics, diagnoses, program duration, human resource utilization and outcomes of patients with chronic daily headache treated in an ambulatory, interdisciplinary, flexible format, treatment and rehabilitation program. BACKGROUND: Research indicates that multidisciplinary care is an effective approach to manage chronic daily headache, but little is known about the resources needed for effective care. METHODS: The study was a secondary data analysis within a cohort design of previously collected data. Patients completed questionnaires and outcome measures on admission and discharge. Diagnoses were extracted from patient charts by professional health records personnel. A central scheduling database provided patient-specific clinician care hours by discipline and type (direct, indirect, group) as well as overall program duration. RESULTS: One hundred and eighteen patients were studied (mean age 41.1 ± 10.4 [x ± SD], 80% female). Sixty-two patients (52.5%) completed the program ("completers"). Migraine was the most common diagnosis. Thirty-six percent of patients had medication overuse. Average pain, mood, disability, and quality of life were significantly improved in completers (P < .001). They utilized 76 ± 45.1 (x ± SD ) total hours of care delivered over a mean of 129.7 ± 66.1 weeks. CONCLUSION: Our study provides evidence that ambulatory, interdisciplinary, flexible format, treatment and rehabilitation programs are effective in the treatment of chronic daily headache, and we provide data on the resources used by our program in the treatment and rehabilitation of these patients.


Subject(s)
Combined Modality Therapy/methods , Headache Disorders/therapy , Adult , Analgesics/therapeutic use , Cohort Studies , Female , Health Resources , Humans , Male , Middle Aged , Neurology/methods , Occupational Therapy/methods , Physical Therapy Modalities , Psychology/methods , Treatment Outcome
2.
PLoS One ; 7(12): e49642, 2012.
Article in English | MEDLINE | ID: mdl-23226500

ABSTRACT

BACKGROUND: Despite the importance of the renin-angiotensin (Ang) system in abdominal aortic aneurysm (AAA) pathogenesis, strategies targeting this system to prevent clinical aneurysm progression remain controversial and unproven. We compared the relative efficacy of two Ang II type 1 receptor blockers, telmisartan and irbesartan, in limiting experimental AAAs in distinct mouse models of aneurysm disease. METHODOLOGY/PRINCIPAL FINDINGS: AAAs were induced using either 1) Ang II subcutaneous infusion (1000 ng/kg/min) for 28 days in male ApoE(-/-) mice, or 2) transient intra-aortic porcine pancreatic elastase infusion in male C57BL/6 mice. One week prior to AAA creation, mice started to daily receive irbesartan (50 mg/kg), telmisartan (10 mg/kg), fluvastatin (40 mg/kg), bosentan (100 mg/kg), doxycycline (100 mg/kg) or vehicle alone. Efficacy was determined via serial in vivo aortic diameter measurements, histopathology and gene expression analysis at sacrifice. Aortic aneurysms developed in 67% of Ang II-infused ApoE(-/-) mice fed with standard chow and water alone (n = 15), and 40% died of rupture. Strikingly, no telmisartan-treated mouse developed an AAA (n = 14). Both telmisartan and irbesartan limited aneurysm enlargement, medial elastolysis, smooth muscle attenuation, macrophage infiltration, adventitial neocapillary formation, and the expression of proteinases and proinflammatory mediators. Doxycycline, fluvastatin and bosentan did not influence aneurysm progression. Telmisartan was also highly effective in intra-aortic porcine pancreatic elastase infusion-induced AAAs, a second AAA model that did not require exogenous Ang II infusion. CONCLUSION/SIGNIFICANCE: Telmisartan suppresses experimental aneurysms in a model-independent manner and may prove valuable in limiting clinical disease progression.


Subject(s)
Angiotensin II Type 1 Receptor Blockers/therapeutic use , Aortic Aneurysm, Abdominal/drug therapy , Angiotensin II Type 1 Receptor Blockers/pharmacology , Animals , Aortic Aneurysm, Abdominal/prevention & control , Apolipoproteins E/genetics , Benzimidazoles/pharmacology , Benzimidazoles/therapeutic use , Benzoates/pharmacology , Benzoates/therapeutic use , Biphenyl Compounds/pharmacology , Biphenyl Compounds/therapeutic use , Bosentan , Doxycycline/pharmacology , Doxycycline/therapeutic use , Fatty Acids, Monounsaturated/pharmacology , Fatty Acids, Monounsaturated/therapeutic use , Fluvastatin , Indoles/pharmacology , Indoles/therapeutic use , Irbesartan , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Sulfonamides/pharmacology , Sulfonamides/therapeutic use , Telmisartan , Tetrazoles/pharmacology , Tetrazoles/therapeutic use
4.
Mol Imaging ; 11(2): 126-34, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22469240

ABSTRACT

Macrophage infiltration is a prominent feature of abdominal aortic aneurysm (AAA) progression. We used a combined imaging approach with bioluminescence (BLI) and magnetic resonance imaging (MRI) to study macrophage homing and accumulation in experimental AAA disease. Murine AAAs were created via intra-aortic infusion of porcine pancreatic elastase. Mice were imaged over 14 days after injection of prepared peritoneal macrophages. For BLI, macrophages were from transgenic mice expressing luciferase. For MRI, macrophages were labeled with iron oxide particles. Macrophage accumulation during aneurysm progression was observed by in situ BLI and by in vivo 7T MRI. Mice were sacrificed after imaging for histologic analysis. In situ BLI (n  =  32) demonstrated high signal in the AAA by days 7 and 14, which correlated significantly with macrophage number and aortic diameter. In vivo 7T MRI (n  =  13) at day 14 demonstrated T2* signal loss in the AAA and not in sham mice. Immunohistochemistry and Prussian blue staining confirmed the presence of injected macrophages in the AAA. BLI and MRI provide complementary approaches to track macrophage homing and accumulation in experimental AAAs. Similar dual imaging strategies may aid the study of AAA biology and the evaluation of novel therapies.


Subject(s)
Aortic Aneurysm, Abdominal/diagnosis , Aortic Aneurysm, Abdominal/pathology , Cell Movement , Luminescent Measurements/methods , Macrophages/pathology , Magnetic Resonance Imaging/methods , Animals , Ferric Compounds/metabolism , Ferrocyanides , Galectin 3/metabolism , Immunohistochemistry , Macrophages/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Staining and Labeling
5.
Perm J ; 15(3): 82-6, 2011.
Article in English | MEDLINE | ID: mdl-22058674

ABSTRACT

Acute occlusive embolism to the coronary arteries resulting in acute myocardial infarction (AMI) is an uncommon occurrence. Although cases of patients with mechanical prosthetic heart valves resulting in this phenomenon have been reported in the setting of inadequate anticoagulation, reported cases resulting years after tissue aortic valve replacement (AVR) are rare. We report the case of a 50-year-old man who underwent a tissue AVR four years earlier and presented to the Emergency Department (ED) with an ST-segment elevation myocardial infarction. ED door-to-balloon time was delayed (at 115 minutes) because of pre-existing left bundle branch block on electrocardiogram. Emergent coronary angiography demonstrated complete occlusion of the left anterior descending coronary artery by a coronary embolus. The patient was successfully treated with percutaneous transluminal coronary angioplasty and aspiration thrombectomy, and subsequently underwent a transesophageal echocardiogram demonstrating thrombus on the tissue aortic valve prosthesis. This case demonstrates that coronary embolism resulting in AMI, while rare, can occur in patients years after tissue AVR surgery.

6.
J Vasc Surg ; 52(4): 975-83, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20678880

ABSTRACT

OBJECTIVE: Diabetes mellitus (DM) is associated with reduced progression of abdominal aortic aneurysm (AAA) disease. Mechanisms responsible for this negative association remain unknown. We created AAAs in hyperglycemic mice to examine the influence of serum glucose concentration on experimental aneurysm progression. METHODS: Aortic aneurysms were induced in hyperglycemic (DM) and normoglycemic models by using intra-aortic porcine pancreatic elastase (PPE) infusion in C57BL/6 mice or by systemic infusion of angiotensin II (ANG) in apolipoprotein E-deficient (ApoE(-/-)) mice, respectively. In an additional DM cohort, insulin therapy was initiated after aneurysm induction. Aneurysmal aortic enlargement progression was monitored with serial transabdominal ultrasound measurements. At sacrifice, AAA cellularity and proteolytic activity were evaluated by immunohistochemistry and substrate zymography, respectively. Influences of serum glucose levels on macrophage migration were examined in separate models of thioglycollate-induced murine peritonitis. RESULTS: At 14 days after PPE infusion, AAA enlargement in hyperglycemic mice (serum glucose ≥ 300 mg/dL) was less than that in euglycemic mice (PPE-DM: 54% ± 19% vs PPE: 84% ± 24%, P < .0001). PPE-DM mice also demonstrated reduced aortic mural macrophage infiltration (145 ± 87 vs 253 ± 119 cells/cross-sectional area, P = .0325), elastolysis (% residual elastin: 20% ± 7% vs 12% ± 6%, P = .0209), and neovascularization (12 ± 8 vs 20 ± 6 vessels/high powered field, P = .0229) compared with PPE mice. Hyperglycemia limited AAA enlargement after ANG infusion in ApoE(-/-) mice (ANG-DM: 38% ± 12% vs ANG: 61% ± 37% at day 28). Peritoneal macrophage production was reduced in response to thioglycollate stimulation in hyperglycemic mice, with limited augmentation noted in response to vascular endothelial growth factor administration. Insulin therapy reduced serum glucose levels and was associated with AAA enlargement rates intermediate between euglycemic and hyperglycemic mice (PPE: 1.21 ± 0.14 mm vs PPE-DM: 1.00 ± 0.04 mm vs PPE-DM + insulin: 1.14 ± 0.05 mm). CONCLUSIONS: Hyperglycemia reduces progression of experimental AAA disease; lowering of serum glucose levels with insulin treatment diminishes this protective effect. Identifying mechanisms of hyperglycemic aneurysm inhibition may accelerate development of novel clinical therapies for AAA disease.


Subject(s)
Aorta, Abdominal , Aortic Aneurysm, Abdominal/complications , Diabetes Mellitus, Experimental/complications , Angiotensin II , Animals , Aorta, Abdominal/diagnostic imaging , Aorta, Abdominal/drug effects , Aorta, Abdominal/metabolism , Aortic Aneurysm, Abdominal/blood , Aortic Aneurysm, Abdominal/chemically induced , Aortic Aneurysm, Abdominal/diagnostic imaging , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Blood Glucose/metabolism , Body Weight , Diabetes Mellitus, Experimental/blood , Diabetes Mellitus, Experimental/drug therapy , Disease Models, Animal , Disease Progression , Hypoglycemic Agents/pharmacology , Insulin/pharmacology , Macrophages/pathology , Male , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Inbred C57BL , Mice, Knockout , Neovascularization, Pathologic/prevention & control , Pancreatic Elastase/metabolism , Peritonitis/chemically induced , Peritonitis/complications , Peritonitis/pathology , Thioglycolates , Time Factors , Ultrasonography , Vascular Endothelial Growth Factor A/administration & dosage
7.
Surgery ; 148(2): 429-35, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20561659

ABSTRACT

BACKGROUND: Extracellular matrix degradation is a sentinel pathologic feature of abdominal aortic aneurysm (AAA) disease. Diabetes mellitus, a negative risk factor for AAA, may impair aneurysm progression through its influence on the fibrinolytic system. We hypothesize that hyperglycemia limits AAA progression through effects on endogenous plasminogen activator inhibitor-1 (PAI-1) levels and subsequent reductions in plasmin generation. METHODS: Experimental AAAs were induced in diabetic and control mice via the intra-aortic elastase infusion method. Serial transabdominal high-frequency ultrasound examinations were performed to monitor aortic diameter following elastase infusion. Circulating PAI-1 and plasmin alpha2-antiplasmin (PAP) complex concentrations were determined by ELISA and local expression of PAI-1 levels was examined by RT-PCR and immunohistochemistry. RESULTS: Hyperglycemia was associated with reduced AAA diameter, increased plasma PAI-1 concentration and reduced plasmin generation. Aneurysmal aortic PAI-1 gene expression increased in parallel with plasma concentration, with peak expression occurring early after aneurysm initiation. CONCLUSION: Hyperglycemia increases PAI-1 expression and attenuates AAA diameter in experimental AAA disease. These results emphasize the role of the fibrinolytic pathway in AAA pathophysiology, and suggest a candidate mechanism for hyperglycemic inhibition of AAA disease.


Subject(s)
Aortic Aneurysm, Abdominal/blood , Aortic Aneurysm, Abdominal/complications , Hyperglycemia/complications , Serpins/blood , Animals , Aorta, Abdominal/metabolism , Aorta, Abdominal/pathology , Aortic Aneurysm, Abdominal/pathology , Aortic Aneurysm, Abdominal/prevention & control , Disease Models, Animal , Fibrinolysin/metabolism , Fibrinolysis , Galectin 3/metabolism , Gene Expression , Humans , Hyperglycemia/blood , Immunohistochemistry , Male , Matrix Metalloproteinase 9/metabolism , Mice , Mice, Inbred C57BL , Risk Factors , Serpin E2 , Serpins/genetics , alpha-2-Antiplasmin/metabolism
8.
Arterioscler Thromb Vasc Biol ; 30(7): 1363-70, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20431069

ABSTRACT

OBJECTIVE: To determine whether procarboxypeptidase B (pCPB)(-/-) mice are susceptible to accelerated abdominal aortic aneurysm (AAA) development secondary to unregulated OPN-mediated mural inflammation in the absence of CPB inhibition. METHODS AND RESULTS: Thrombin/thrombomodulin cleaves thrombin-activatable pCPB or thrombin-activatable fibrinolysis inhibitor, activating CPB, which inhibits the generation of plasmin and inactivates proinflammatory mediators (complement C5a and thrombin-cleaved osteopontin [OPN]). Apolipoprotein E(-/-)OPN(-/-) mice are protected from experimental AAA formation. Murine AAAs were created via intra-aortic porcine pancreatic elastase (PPE) infusion. Increased mortality secondary to AAA rupture was observed in pCPB(-/-) mice at the standard PPE dose. At reduced doses of PPE, pCPB(-/-) mice developed larger AAAs than wild-type controls (1.01+/-0.27 versus 0.68+/-0.05 mm; P=0.02 [mean+/-SD]). C5(-/-) and OPN(-/-) mice were not protected against AAA development. Treatment with tranexamic acid inhibited plasmin generation and abrogated enhanced AAA progression in pCPB(-/-) mice. CONCLUSIONS: This study establishes the role of CPB in experimental AAA disease, indicating that CPB has a broad anti-inflammatory role in vivo. Enhanced AAA formation in the PPE model is the result of increased plasmin generation, not unregulated C5a- or OPN-mediated mural inflammation.


Subject(s)
Aortic Aneurysm, Abdominal/enzymology , Aortic Rupture/enzymology , Carboxypeptidase B2/deficiency , Animals , Antifibrinolytic Agents/pharmacology , Aortic Aneurysm, Abdominal/chemically induced , Aortic Aneurysm, Abdominal/genetics , Aortic Aneurysm, Abdominal/pathology , Aortic Aneurysm, Abdominal/prevention & control , Aortic Rupture/chemically induced , Aortic Rupture/genetics , Aortic Rupture/pathology , Aortic Rupture/prevention & control , Apolipoproteins E/deficiency , Apolipoproteins E/genetics , Carboxypeptidase B2/genetics , Complement C5a/metabolism , Disease Models, Animal , Disease Progression , Fibrinolysin/metabolism , Inflammation Mediators/blood , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Osteopontin/deficiency , Osteopontin/genetics , Pancreatic Elastase , Time Factors , Tranexamic Acid/pharmacology
9.
J Clin Invest ; 120(3): 694-705, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20179352

ABSTRACT

Despite the high doses of radiation delivered in the treatment of patients with glioblastoma multiforme (GBM), the tumors invariably recur within the irradiation field, resulting in a low cure rate. Understanding the mechanism of such recurrence is therefore important. Here we have shown in an intracranial GBM xenograft model that irradiation induces recruitment of bone marrow-derived cells (BMDCs) into the tumors, restoring the radiation-damaged vasculature by vasculogenesis and thereby allowing the growth of surviving tumor cells. BMDC influx was initiated by induction of HIF-1 in the irradiated tumors, and blocking this influx prevented tumor recurrence. Previous studies have indicated that BMDCs are recruited to tumors in part through the interaction between the HIF-1-dependent stromal cell-derived factor-1 (SDF-1) and its receptor, CXCR4. Pharmacologic inhibition of HIF-1 or of the SDF-1/CXCR4 interaction prevented the influx of BMDCs, primarily CD11b+ myelomonocytes, and the postirradiation development of functional tumor vasculature, resulting in abrogation of tumor regrowth. Similar results were found using neutralizing antibodies against CXCR4. Our data therefore suggest a novel approach for the treatment of GBM: in addition to radiotherapy, the vasculogenesis pathway needs to be blocked, and this can be accomplished using the clinically approved drug AMD3100, a small molecule inhibitor of SDF-1/CXCR4 interactions.


Subject(s)
Antineoplastic Agents/pharmacology , Brain Neoplasms/therapy , Glioblastoma/therapy , Heterocyclic Compounds/pharmacology , Neoplasm Recurrence, Local/therapy , Neovascularization, Pathologic/therapy , Whole-Body Irradiation , Animals , Anti-HIV Agents , Antibodies, Neutralizing , Antineoplastic Agents/therapeutic use , Benzylamines , Bone Marrow Cells/metabolism , Bone Marrow Cells/pathology , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , CD11b Antigen/metabolism , Cell Line, Tumor , Cell Movement/drug effects , Cell Movement/radiation effects , Chemokine CXCL12/antagonists & inhibitors , Chemokine CXCL12/metabolism , Cyclams , Glioblastoma/metabolism , Glioblastoma/pathology , Heterocyclic Compounds/therapeutic use , Humans , Hypoxia-Inducible Factor 1/metabolism , Mice , Mice, Nude , Monocytes/metabolism , Monocytes/pathology , Neoplasm Recurrence, Local/metabolism , Neoplasm Recurrence, Local/pathology , Neoplasm Transplantation , Neovascularization, Pathologic/metabolism , Neovascularization, Pathologic/pathology , Receptors, CXCR4/antagonists & inhibitors , Receptors, CXCR4/metabolism , Transplantation, Heterologous
10.
Cardiovasc Eng Technol ; 1(1)2010 Mar.
Article in English | MEDLINE | ID: mdl-24324530

ABSTRACT

PURPOSE: Hemodynamic forces are thought to play a critical role in abdominal aortic aneurysm (AAA) growth. In silico and in vitro simulations can be used to study these forces, but require accurate aortic geometries and boundary conditions. Many AAA simulations use patient-specific geometries, but utilize inlet boundary conditions taken from a single, unrelated, healthy young adult. METHODS: In this study, we imaged 43 AAA patients using a 1.5 T MR scanner. A 24-frame cardiac-gated one-component phase-contrast magnetic resonance imaging sequence was used to measure volumetric flow at the supraceliac (SC) and infrarenal (IR) aorta, where flow information is typically needed for simulation. For the first 36 patients, individual waveforms were interpolated to a 12-mode Fourier curve, peak-aligned, and averaged. Allometric scaling equations were derived from log-log plots of mean SC and IR flow vs. body mass, height, body surface area (BSA), and fat-free body mass. The data from the last seven patients were used to validate our model. RESULTS: Both the SC and IR averaged waveforms had the biphasic shapes characteristic of older adults, and mean SC and IR flows over the cardiac cycle were 51.2 ± 10.3 and 17.5 ± 5.44 mL/s, respectively. Linear regression of the log-log plots revealed that BSA was most strongly predictive of mean SC (R2 = 0.29) and IR flow (R2 = 0.19), with the highest combined R2. When averaged, the measured and predicted waveforms for the last seven patients agreed well. CONCLUSIONS: We present a method to estimate SC and IR mean flows and waveforms for AAA simulation.

11.
Am J Physiol Heart Circ Physiol ; 296(5): H1329-35, 2009 May.
Article in English | MEDLINE | ID: mdl-19304942

ABSTRACT

Apelin is a potent inodilator with recently described antiatherogenic properties. We hypothesized that apelin might also attenuate abdominal aortic aneurysm (AAA) formation by limiting disease-related vascular wall inflammation. C57BL/6 mice implanted with osmotic pumps filled with apelin or saline were treated with pancreatic elastase to create infrarenal AAAs. Mice were euthanized for aortic PCR analysis or followed ultrasonographically and then euthanized for histological analysis. The cellular expression of inflammatory cytokines and chemokines in response to apelin was also assessed in cultured macrophages, smooth muscle cells, and fibroblasts. Apelin treatment resulted in diminished AAA formation, with a 47% reduction in maximal cross-sectional area (0.74 vs. 1.39 mm(2), P < 0.03) and a 57% reduction in macrophage infiltrate (113 vs. 261.3 cells/high-power field, P < 0.0001) relative to the saline-treated group. Apelin infusion was also associated with significantly reduced aortic macrophage colony-stimulating factor expression and decreased monocyte chemattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-1alpha, interleukin (IL)-6, and tumor necrosis factor (TNF)-alpha mean mRNA levels. Apelin stimulation of cultured macrophages significantly reduced MCP-1 and TNF-alpha mRNA levels relative to baseline (2.03- and 1.89-fold reduction, P < 0.03, respectively) but did not affect intimal adhesion molecule expression or medial or adventitial cell cytokine production. Apelin significantly reduces aneurysm formation in the elastase model of human AAA disease. The mechanism appears to be decreased macrophage burden, perhaps related to an apelin-mediated decrease in proinflammatory cytokine and chemokine activation.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Aorta, Abdominal/drug effects , Aortic Aneurysm, Abdominal/prevention & control , Aortitis/prevention & control , Intercellular Signaling Peptides and Proteins/administration & dosage , Macrophages/drug effects , Animals , Aorta, Abdominal/diagnostic imaging , Aorta, Abdominal/immunology , Aorta, Abdominal/pathology , Aortic Aneurysm, Abdominal/chemically induced , Aortic Aneurysm, Abdominal/immunology , Aortitis/chemically induced , Aortitis/immunology , Chemokines/genetics , Chemokines/metabolism , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Down-Regulation , Immunohistochemistry , Inflammation Mediators/metabolism , Infusion Pumps, Implantable , Macrophages/immunology , Male , Mice , Mice, Inbred C57BL , NIH 3T3 Cells , Pancreatic Elastase , Rats , Reverse Transcriptase Polymerase Chain Reaction , Ultrasonography
SELECTION OF CITATIONS
SEARCH DETAIL
...